|
|
|
Corporate Profile: Somagenics
| Summary: |
| Somagenics aims to become
the premier developer of innovative DNA- and RNA-based
technologies for the improvement of human health. |
| Address (HQ):
|
2161 Delaware Avenue
Santa Cruz, CA 95060 |
| Phone #'s (HQ): |
Main |
(831) 426-7700 |
| Human Resources |
(831) 426-7700 |
| Investor Relations |
(831) 426-7700 |
| Fax #'s (HQ): |
Main |
(831) 420-0685 |
| Human Resources |
(831) 420-0685 |
| Investor Relations |
(831) 420-0685 |
| Financial
information: |
| Somagenics
has funded its early, high-risk studies to develop
and validate the technology through 15 government
grants and contracts totaling about $4.5 million
over the past four years, mostly through the Small
Business Innovation Research Program of the US National
Institutes of Health (NIH), the Defense Advanced
Research Projects Agency (DARPA) and the US National
Science Foundation (NSF). |
| Issued United States patents: |
Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
